VAGISTAT-1 Drug Patent Profile
✉ Email this page to a colleague
When do Vagistat-1 patents expire, and when can generic versions of Vagistat-1 launch?
Vagistat-1 is a drug marketed by Combe and is included in one NDA.
The generic ingredient in VAGISTAT-1 is tioconazole. There are three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tioconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vagistat-1
A generic version of VAGISTAT-1 was approved as tioconazole by PERRIGO on November 21st, 2001.
Summary for VAGISTAT-1
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Patent Applications: | 4,751 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VAGISTAT-1 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VAGISTAT-1
US Patents and Regulatory Information for VAGISTAT-1
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combe | VAGISTAT-1 | tioconazole | OINTMENT;VAGINAL | 020676-001 | Feb 11, 1997 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |